{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:11:39Z","timestamp":1768414299252,"version":"3.49.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100342, 81873432 , 82070143"],"award-info":[{"award-number":["81100342, 81873432 , 82070143"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Prolonged isolated thrombocytopenia (PT) is a common complication affecting the outcome of stem cell transplantation. In this study, we undertook a real-world study of 303 myelodysplastic syndrome (MDS) patients who received allogeneic hematopoietic stem cell transplantation (HSCT) between December 2007 and June 2018. 28.4% of MDS patients suffered from PT after HSCT. Survival analysis indicated that PT was associated with worse overall survival (OS) in MDS patients. The 2-year and 5-year OS in MDS patients with PT after HSCT were 49% and 47%, significantly worse than that of 68% and 60% in patients without PT (P=0.005). For RFS, patients with PT did not have an increased risk of disease relapse (P=0.964). After multivariate adjustment, PT was proved to be the independent risk factor associated with the worse OS (HR 1.49, 95% CI 1.00-2.21, P =0.048). We further analyzed risk factors associated with the occurrence of PT in MDS patients. Multiple logistic regression identified grade II-IV aGVHD, extensive chronic GVHD, hemorrhagic cystitis, and CMV activation as significant risk factors for developing PT. Among these variables, the Odds Ratio (OR) of grade II-IV aGVHD was the highest (P =0.001, OR: 2.65, 95% CI: 1.51-4.64). These data indicated the prognostic value of PT in MDS after HSCT. The identification of risk factors for PT may help improve patient management and lead to the design of effective treatment strategies.<\/jats:p>","DOI":"10.3389\/fonc.2022.940320","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T07:35:07Z","timestamp":1657524907000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic Value of Thrombocytopenia in Myelodysplastic Syndromes After Hematopoietic Stem Cell Transplantation"],"prefix":"10.3389","volume":"12","author":[{"given":"Hong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantian","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiying","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengcheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changgeng","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701499","article-title":"Prolonged Isolated Thrombocytopenia After Hematopoietic Stem Cell Transplantation: Morphologic Correlation","volume":"22","author":"Bielski","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.2001.v7.pm11302549","article-title":"Secondary Failure of Platelet Recovery After Hematopoietic Stem Cell Transplantation","volume":"7","author":"Bruno","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V65.2.368.368","article-title":"Isolated Thrombocytopenia After Allogeneic Bone Marrow Transplantation: Existence of Transient and Chronic Thrombocytopenic Syndromes","volume":"65","author":"First","year":"1985","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.06.010","article-title":"Recombinant Human Thrombopoietin Promotes Platelet Engraftment and Improves Prognosis of Patients With Myelodysplastic Syndromes and Aplastic Anemia After Allogeneic Hematopoietic Stem Cell Transplantation","volume":"23","author":"Wang","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2440-x","article-title":"The Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function After Unmanipulated Haploidentical Stem Cell Transplantation","volume":"94","author":"Sun","year":"2015","journal-title":"Ann Hematol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1043836","article-title":"Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation","volume":"2017","author":"Zhao","year":"2017","journal-title":"J Immunol Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705444","article-title":"Prolonged Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation: Associations With Impaired Platelet Production and Increased Platelet Turnover","volume":"38","author":"Yamazaki","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V73.4.1054.1054","article-title":"Graft-V-Host Disease is Associated With Autoimmune-Like Thrombocytopenia","volume":"73","author":"Anasetti","year":"1989","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.02.001","article-title":"Platelet Engraftment in Patients With Hematologic Malignancies Following Unmanipulated Haploidentical Blood and Marrow Transplantation: Effects of CD34+ Cell Dose and Disease Status","volume":"15","author":"Chang","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.044966","article-title":"Cytopenias After Day 28 in Allogeneic Hematopoietic Cell Transplantation: Impact of Recipient\/Donor Factors, Transplant Conditions and Myelotoxic Drugs","volume":"96","author":"Nakamae","year":"2011","journal-title":"Haematologica"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.3.844.844","article-title":"Cytomegalovirus Infection Causes Delayed Platelet Recovery After Bone Marrow Transplantation","volume":"78","author":"Verdonck","year":"1991","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.07.014","article-title":"Association of an Impaired Bone Marrow Microenvironment With Secondary Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation","volume":"19","author":"Kong","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.04.015","article-title":"Association Between an Impaired Bone Marrow Vascular Microenvironment and Prolonged Isolated Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation","volume":"20","author":"Kong","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.02.021","article-title":"Abnormalities of the Bone Marrow Immune Microenvironment in Patients With Prolonged Isolated Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation","volume":"23","author":"Song","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.09.007","article-title":"Prolonged Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation and its Association With a Reduction in Ploidy and an Immaturation of Megakaryocytes","volume":"17","author":"Zhang","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705203","article-title":"Prognostic Significance of Platelet Recovery Pattern After Allogeneic HLA-Identical Sibling Transplantation and its Association With Severe Acute GVHD","volume":"37","author":"Kim","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02468.x","article-title":"Factors Influencing Haematological Recovery After Allogeneic Haemopoietic Stem Cell Transplants: Graft-Versus-Host Disease, Donor Type, Cytomegalovirus Infections and Cell Dose","volume":"112","author":"Dominietto","year":"2001","journal-title":"Br J Haematol"},{"key":"B18","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood.V66.3.752.752","article-title":"Autoimmune Thrombocytopenia and Neutropenia After Bone Marrow Transplantation","volume":"66","author":"Minchinton","year":"1985","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.5.2097","article-title":"Association of Specific Cytomegalovirus Genotypes With Death From Myelosuppression After Marrow Transplantation","volume":"90","author":"Torok-Storb","year":"1997","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.4.1277.bloodjournal8841277","article-title":"Direct Infection of CD34+ Progenitor Cells by Human Cytomegalovirus: Evidence for Inhibition of Hematopoiesis and Viral Replication","volume":"88","author":"Movassagh","year":"1996","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.6.2482","article-title":"Spread of Human Cytomegalovirus (HCMV) After Infection of Human Hematopoietic Progenitor Cells: Model of HCMV Latency","volume":"90","author":"Zhuravskaya","year":"1997","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.10.1965.1965","article-title":"Preferential Suppression of Myelopoiesis in Normal Human Bone Marrow Cells After In Vitro Challenge With Human Cytomegalovirus","volume":"75","author":"Sing","year":"1990","journal-title":"Blood"},{"key":"B23","article-title":"IL2 Activated Killer Cells may Contribute to Cytomegalovirus Induced Marrow Hypoplasia After Bone Marrow Transplantation","volume":"7","author":"Duncombe","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.1.170.bloodjournal801170","article-title":"Infection of Hematopoietic Progenitor Cells by Human Cytomegalovirus","volume":"80","author":"Maciejewski","year":"1992","journal-title":"Blood"},{"key":"B25","first-page":"38","article-title":"The Effect of Cytomegalovirus on Hemopoiesis: In Vitro Evidence for Selective Infection of Marrow Stromal Cells","volume":"17","author":"Apperley","year":"1989","journal-title":"Exp Hematol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.2.487","article-title":"In Vitro Infection of Megakaryocytes and Their Precursors by Human Cytomegalovirus","volume":"95","author":"Crapnell","year":"2000","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.162","article-title":"Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation: Risk Factors, Graft Source and Survival","volume":"50","author":"Lunde","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2815","article-title":"Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation: Donor Type Matters","volume":"103","author":"El-Zimaity","year":"2004","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/s1083-8791(03)00269-6","article-title":"Hemorrhagic Cystitis After Allogeneic Bone Marrow Transplantation in Children: Clinical Characteristics and Outcome","volume":"9","author":"Hale","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705886","article-title":"Polyomavirus BK Infection in Blood and Marrow Transplant Recipients","volume":"41","author":"Dropulic","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.2.194","article-title":"Hemorrhagic Cystitis Following High-Dose Chemotherapy and Bone Marrow Transplantation in Children With Malignancies: Incidence, Clinical Course, and Outcome","volume":"7","author":"Brugieres","year":"1989","journal-title":"J Clin Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1432-2277.2006.00404.x","article-title":"Risk Factors and Treatment of Hemorrhagic Cystitis in Children Who Underwent Hematopoietic Stem Cell Transplantation","volume":"20","author":"Cheuk","year":"2007","journal-title":"Transpl Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703814","article-title":"Cyclic Recovery of Adenovirus in a Stem Cell Transplant Recipient: An Inverse Association With Graft-Versus-Host Disease","volume":"31","author":"Echavarria","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410x.1988.tb04439.x","article-title":"Severe Cystitis as a Manifestation of Chronic Graft-Versus-Host Disease After Bone Marrow Transplantation","volume":"62","author":"Ruutu","year":"1988","journal-title":"Br J Urol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.181","article-title":"The Risk of Polyomavirus BK-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic SCT is Associated With Myeloablative Conditioning, CMV Viremia and Severe Acute GVHD","volume":"49","author":"Uhm","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1179\/1607845412Y.0000000010","article-title":"Risk Factors for and Prognosis of Hemorrhagic Cystitis After Allogeneic Stem Cell Transplantation: Retrospective Analysis in a Single Institution","volume":"17","author":"Arai","year":"2012","journal-title":"Hematology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(90)90146-i","article-title":"Human Cytomegalovirus Major Immediate Early Gene Product can Induce SV40 DNA Replication in Human Embryonic Lung Cells","volume":"179","author":"Pari","year":"1990","journal-title":"Virology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703187","article-title":"CMV Reactivation Induced BK Virus-Associated Late Onset Hemorrhagic Cystitis After Peripheral Blood Stem Cell Transplantation","volume":"28","author":"Bielorai","year":"2001","journal-title":"Bone Marrow Transplant"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.940320\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T07:35:10Z","timestamp":1657524910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.940320\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,11]]},"references-count":38,"alternative-id":["10.3389\/fonc.2022.940320"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.940320","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,11]]},"article-number":"940320"}}